Circulating Tumor Cells: Evolving Evidence and Future Challenges
-
- Efrat Dotan
- Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
-
- Steven J. Cohen
- Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
-
- Katherine R. Alpaugh
- Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
-
- Neal J. Meropol
- Division of Hematology-Oncology, University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA
Description
<jats:title>Abstract</jats:title> <jats:p>Circulating tumor cells (CTCs) are rare malignant cells found in the peripheral blood that originate from the primary tumor or metastatic sites. New techniques have been developed to isolate and characterize these cells. CTC enumeration has been incorporated into different fields of oncology as a prognostic marker, a tool to monitor therapy response, and a method to understand basic tumor characteristics. This review covers the different techniques available for isolation of CTCs, the clinical utility of CTCs in breast, prostate, and colon cancer, and future directions in this field.</jats:p>
Journal
-
- The Oncologist
-
The Oncologist 14 (11), 1070-1082, 2009-11-01
Oxford University Press (OUP)
- Tweet
Details 詳細情報について
-
- CRID
- 1363107370647221760
-
- ISSN
- 1549490X
- 10837159
-
- Data Source
-
- Crossref